Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Gains 5%; BSE HEALTHCARE Index Up 0.3%
Tue, 13 Aug 13:0

STRIDES PHARMA SCIENCE Gains 5%; BSE HEALTHCARE Index Up 0.3%Image source: Eoneren/www.istockphoto.com

STRIDES PHARMA SCIENCE share price has zoomed 5% and is presently trading at Rs 1,188.2.

Meanwhile, the BSE HEALTHCARE index is at 41,166.0 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 4.9%) and Aurobindo Pharma (up 4.2%).

Cadila Healthcare (down 5.2%) and GLAND PHARMA (down 2.6%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 437.4 to Rs 1,188.2, registering a gain of Rs 750.9 (up 171.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,485.8 to 41,166.0, registering a gain of 44.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 110.5%), GRANULES INDIA (up 110.0%) and SUVEN PHARMACEUTICALS (up 105.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,309.6 (down 0.4%).

The top losers among the BSE Sensex today are HDFC Bank (down 2.7%) and Tata Motors (down 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,234.3 (down 0.5%). HDFC Bank and HDFC LIFE INSURANCE are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,995.8 to 79,309.6, registering a gain of 13,313.8 points (up 20.2%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit grew 239.9% YoY to Rs 801 million for the quarter ended June 2024, compared to a profit of Rs 236 million a year ago. Net sales rose 16.9% to Rs 10,875 million during the period as against Rs 9,300 million in April-June 2023.

For the year ended March 2023, STRIDES PHARMA SCIENCE reported 51.3% increase in net profit to Rs -2,309 million compared to net loss of Rs 4,743 million during FY22. Revenue of the company grew 20.1% to Rs 36,884 million during FY23.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 130.5.


Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Gains 5%; BSE HEALTHCARE Index Up 0.3%". Click here!